Live tape
Top 8, mentions 7d7,547META2,266 mentions▲ +0.06GOOGL1,512 mentions▲ +0.02NVDA806 mentions▲ +0.09MUSE666 mentions▲ +0.07MSFT606 mentions▲ +0.06SPY573 mentions▲ +0.05QQQ564 mentions▲ +0.08TSLA554 mentions▲ +0.06

Equity · Healthcare

BWAY

BrainsWay Ltd. · NasdaqGM

$13.30 0.00% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 25, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$17 $13 30 Jun 25 Sep

The line runs $15.50 on 30 June through $13.30 on 25 September, on a scale from $13 to $17. Days the market did not trade hold the previous close, flat.

The chart above plots the price of BWAY over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $15.50 on 30 June 2026 through $13.30 on 25 September 2026.

52-week range $7.33 – $17
Avg volume 3.6K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · as of Sep 25, 2026

Filings 2 sets

BWAY institutional holders

SEC Form 13F

5 of the 45 institutional funds we track reported a BWAY position for the quarter ended 30 Jun 2026 — a combined $12.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −8.2% shares 475,920 $7.4M
ARK Investment Management Trimmed −26.4% shares 142,500 $2.2M
Two Sigma Investments Held (±25%) −22.3% shares 99,545 $1.5M
Citadel Advisors Trimmed −45.4% shares 47,519 $737K
Man Group Held (±25%) +0.9% shares 27,474 $426K

Source: SEC EDGAR 13F filings

BWAY fails-to-deliver

SEC CNS data

On 25 Aug 2026, 229 shares of BWAY failed to deliver (about $3K).

Settlement date Shares failed Notional % of shares out
25 Aug 2026 229 $3K 0.001%
21 Aug 2026 230 $3K 0.001%
17 Aug 2026 56 $914 <0.001%

Source: SEC fails-to-deliver (CNS) data